Targeted radiotherapy to the skeleton using 166HO-DOTMP with autologous stem cell transplantation for patients with bone-only metastatic breast cancer

被引：2
|
作者：
Champlin, RE [1 ]
Booser, D [1 ]
Rondon, G [1 ]
Williams, PA [1 ]
Wendt, R [1 ]
Hortobagyi, G [1 ]
Ueno, N [1 ]
Podoloff, D [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.249
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
249
引用
收藏
页码：84 / 85
页数：2
相关论文
共 50 条
  • [1] Targeted radiotherapy to the skeleton using 166Ho-DOTMP with autologous stem cell transplantation for patients with bone-only metastatic breast cancer
    Champlin, R
    Booser, D
    Rondon, G
    Williams, P
    Wendt, R
    Hortobagyi, G
    Ueno, N
    Podoloff, D
    BLOOD, 2004, 104 (11) : 395B - 395B
  • [2] 166Ho-DOTMP Skeletal Targeted Radiotherapy with melphalan and autologous stem cell support for multiple myeloma
    Bensinger, W
    Giralt, S
    Goodman, M
    Salzman, D
    Ruffner, K
    Breitz, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 596S - 596S
  • [3] Complete response of bone-only metastatic breast cancer to skeletal:: Targeted radiotherapy with 166HOLMIUM-DOTMP.
    Booser, DJ
    Ueno, NT
    Rondon, G
    Williams, PA
    Wendt, R
    Hortobagyi, GN
    Podoloff, DA
    Champlin, RE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 21S - 21S
  • [4] 166Ho-DOTMP Skeletal Targeted Radiotherapy™ as conditioning for peripheral blood stem cell transplant for patients with multiple myeloma
    Breitz, H
    Wendt, R
    Stabin, M
    Shen, S
    Rajendran, JG
    Meredith, R
    Martin, W
    Serafini, A
    Delpassand, E
    Bensinger, W
    Salzman, D
    Ruffner, K
    Goodman, M
    Giralt, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S291 - S292
  • [5] Pharmacokinetics and patient specific dosimetry of high dose 166Ho-DOTMP therapy used for treatment of breast cancer metastatic to bone.
    McCullough, SP
    Wendt, RE
    Macey, DJ
    Zareneyrizi, F
    Champlin, RE
    Podoloff, DA
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 40P - 40P
  • [6] A phase II study to evaluate radiation dosimetry, pharmacolkinetics and safety of 166Ho-DOTMP in patients with multiple myeloma undergoing autologous transplantation
    Bensinger, W
    Giralt, S
    Salzman, D
    Ruffner, K
    Sims, R
    Breitz, H
    BLOOD, 2003, 102 (11) : 984A - 985A
  • [7] Holmium-166 (166Ho)-DOTMP skeletal targeted radiotherapy (STR™) with melphalan and autologous peripheral stem cell transplant (PBSCT) for multiple myeloma (MM).
    Goodman, M
    Bensinger, WI
    Giralt, S
    Salzman, D
    Ruffner, KL
    Breitz, HB
    BLOOD, 2004, 104 (11) : 264A - 264A
  • [8] Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only Metastases
    Parkes, Amanda
    Warneke, Carla L.
    Clifton, Katherine
    Al-Awadhi, Aydah
    Oke, Oluchi
    Pestana, Roberto Carmagnani
    Alhalabi, Omar
    Litton, Jennifer K.
    Hortobagyi, Gabriel N.
    ONCOLOGIST, 2018, 23 (11): : 1282 - 1288
  • [9] 166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma:: results of two phase 1/2 trials
    Giralt, S
    Bensinger, W
    Goodman, M
    Podoloff, D
    Eary, J
    Wendt, R
    Alexanian, R
    Weber, D
    Maloney, D
    Holmberg, L
    Rajandran, J
    Breitz, H
    Ghalie, R
    Champlin, R
    BLOOD, 2003, 102 (07) : 2684 - 2691
  • [10] Pilot Study of Targeted Skeletal Radiation Therapy for Bone-Only Metastatic Breast Cancer
    Ueno, Naoto T.
    de Souza, Jonas A.
    Booser, Daniel
    Nakayama, Kazutaka
    Madewell, John
    Wendt, Richard E., III
    Hortobagyi, Gabriel N.
    Podoloff, Donald
    Charnplin, Richard E.
    CLINICAL BREAST CANCER, 2009, 9 (03) : 173 - 177
12345